# Predictors of AIS Unfavorable Outcomes

> **NCT06058884** · PHASE4 · COMPLETED · sponsor: **Kafrelsheikh University** · enrollment: 592 (actual)

## Conditions studied

- Ischemic Stroke
- Alteplase Adverse Reaction

## Interventions

- **DRUG:** Alteplase

## Key facts

- **NCT ID:** NCT06058884
- **Lead sponsor:** Kafrelsheikh University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-01-03
- **Primary completion:** 2023-06-03
- **Final completion:** 2023-06-29
- **Target enrollment:** 592 (ACTUAL)
- **Last updated:** 2023-10-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06058884

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06058884, "Predictors of AIS Unfavorable Outcomes". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06058884. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*